NuCana (NCNA) Depreciation & Amortization (CF) (2017 - 2025)

NuCana's (NCNA) quarterly Depreciation & Amortization (CF) came in at $91781.5 in Q4 2025, down 37.82% year-on-year from $147602.7 in Q4 2024, and down 1.42% quarter-over-quarter from $93106.0 in Q3 2025.

NuCana (NCNA) Depreciation & Amortization (CF) (2017 - 2025) Analysis & Trends

NuCana has disclosed Depreciation & Amortization (CF) across 9 years of filings, most recently posting $91781.5 for Q4 2025.

  • Depreciation & Amortization (CF) for Q4 2025 came in at $91781.5, down 37.82% year-over-year; the trailing twelve-month figure through Dec 2025 was $184887.5 (down 72.29% YoY), and the FY2025 annual result was $361271.8, down 45.86% from the prior year.
  • Depreciation & Amortization (CF) came in at $91781.5 for Q4 2025 at NuCana, down from $93106.0 in the prior quarter.
  • In the past five years, Depreciation & Amortization (CF) ranged from a high of $362614.9 in Q4 2021 to a low of $91781.5 in Q4 2025.
  • The 5-year median for Depreciation & Amortization (CF) is $178426.6 (2023), against an average of $216883.8.
  • Across the five-year window, Depreciation & Amortization (CF) advanced 23.15% in 2021 and plunged 47.22% in 2023, its largest moves.
  • NuCana's Depreciation & Amortization (CF) stood at $362614.9 in 2021, then decreased by 5.19% to $343792.8 in 2022, then slumped by 49.1% to $175002.4 in 2023, then retreated by 15.66% to $147602.7 in 2024, then plunged by 37.82% to $91781.5 in 2025.
  • The last three Depreciation & Amortization (CF) figures came in at $91781.5 (Q4 2025), $93106.0 (Q3 2025), and $147602.7 (Q4 2024), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Depreciation & Amortization (Qtr)
1 Alterity Therapeutics 723,416.35 Bn 723,416.32 Bn - 1,395.22
2 Belite Bio 57,340.00 Bn 57,340.00 Bn - -
3 Quantum Biopharma 19,125.08 Bn 19,125.08 Bn - -
4 Legend Biotech 3,262.00 Bn 3,261.71 Bn 242.10 Mn -
5 Akari Therapeutics 1,789.67 Bn 1,789.67 Bn - -
6 Evaxion A 1,480.39 Bn 1,480.37 Bn - -
7 Psyence Biomedical 241.78 Bn 241.78 Bn - -1,330.00
8 Vertex Pharmaceuticals 113.54 Bn 106.29 Bn 2.59 Bn 55.90 Mn
9 Abivax 94.26 Bn 94.26 Bn - 429,663.65
10 NuCana 29.13 Bn 29.13 Bn - 91,781.47

Historic Data

Download Data
DateValue
Dec 31, 2025 91,781.47
Dec 31, 2025 91,781.47
Sep 30, 2025 93,105.99
Sep 30, 2025 93,105.99
Dec 31, 2024 147,602.71
Dec 31, 2024 147,602.71
Sep 30, 2024 175,405.52
Sep 30, 2024 175,405.52
Jun 30, 2024 171,662.02
Jun 30, 2024 171,662.02
Mar 31, 2024 172,518.47
Mar 31, 2024 172,518.47
Dec 31, 2023 175,002.42
Dec 31, 2023 175,002.42
Sep 30, 2023 184,935.98
Sep 30, 2023 184,935.98
Jun 30, 2023 181,447.66
Jun 30, 2023 181,447.66
Mar 31, 2023 173,817.86
Mar 31, 2023 173,817.86